Skip to main content

Web Exclusives

FDA Updates
Pembrolizumab plus Lenvatinib Combination Receives Regular Approval for Advanced Endometrial Carcinoma
Read More
FDA Updates
Padcev Receives Regular FDA Approval for Locally Advanced or Metastatic Urothelial Cancer
Read More
FDA Updates
FDA Alert: Pepaxto (Melphalan Flufenamide) Associated with Increased Risk of Death in Postmarketing Clinical Trial
Read More
Breast Cancer, FDA Updates
FDA Approves Margenza for Treatment of Metastatic HER2-Positive Breast Cancer
Read More
Cholangiocarcinoma
Emerging Molecular Targets in Cholangiocarcinoma: IDH1, HER2, BRAF, and Beyond
Read More
Cholangiocarcinoma
Combination of NUC-1031 plus Cisplatin Shows Promise as First-Line Treatment for Advanced Biliary Tract Cancer
Read More
Cholangiocarcinoma
FGFR Inhibition in Cholangiocarcinoma: Overcoming Acquired Resistance
Read More
Cholangiocarcinoma
Targeted Therapies in Cholangiocarcinoma: Next-Generation Sequencing Is a Must
Read More
Cholangiocarcinoma
Using Tumor Organoid-Based Functional Analysis to Predict Drug Sensitivities in Patients with Cholangiocarcinoma
Read More
Cholangiocarcinoma
Improving Chemotherapy Combinations and Novel Treatments Are Needed in Advanced Biliary Tract Cancer
Read More
Page 6 of 43
Results 51 - 60 of 425